Clinical trial
Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
NCT00259857 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00259857 |
|---|---|
| Title | Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Prospective, Cross-Over Phase II Clinical Trial to Determine the Safety and Efficacy of Alendronate (Fosamax) in Juvenile Osteoporosis (IND#60,017) |
| Lead sponsor | Medical University of South Carolina, Other |
| Collaborators | FDA Office of Orphan Products Development U.S. Fed Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Alendronate |
| Enrollment | 22 |
| Start date | Oct 1, 2003 |
| Primary completion | Mar 1, 2008 |
| Completion | Aug 1, 2009 |
| First posted | Dec 1, 2005 |
| Last update posted | Jan 19, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: